Skip to main content

Parkwalk Advisors — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

173
Companies
$2.2B
Total invested
$14.2M
Avg. check
51
Industries
Software 10Biotechnology 5Health Care 5Artificial Intelligence (AI) 5Machine Learning 4Manufacturing 3+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 124 of 173
Focal Point Positioning
September 2022

FocalPoint has developed next generation navigation and positioning software for smartphones, wearables and autonomous vehicles.

Consulting · Cambridge$26.5M Series C
PetMedix
September 2021

PetMedix is a pet therapeutics startup.

Biotechnology · Cambridge$37.2M Series B
Crypto Quantique
September 2023

Crypto Quantique offers hardware based cyber-security solution for authentication and encryption in a wired local network.

Cyber Security · City Of LondonNon-equity Assistance
Opsydia
September 2022

Opsydia is set to disrupt a number of industries by its ability to create practically invisible structures inside transparent materials.

Electronics · Oxford$4.0M Venture - Series Unknown
Trismik
September 2025

Trismik is an early-stage company specializing in efficient real-world evaluations, particularly for LLMs.

Information Technology · Cambridge$3.0M Pre-Seed
Cheesecake Energy
September 2024

Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy.

Energy · NottinghamGrant
Duel
September 2025

A Brand Advocacy Platform that enables brands to transform customers into their biggest acquisition channel

Advertising · London$16.0M Series A
Enhanc3D Genomics
September 2025

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Biotechnology · Cambridge$5.4M Series A
PhoreMost
September 2024

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Biopharma · Cambridge$12.0M Series B
Nozzle.ai
August 2021

Nozzle.ai is an eCommerce and advertising optimization platform for Amazon.

Advertising · London$2.1M Series A
Gripable
August 2022

Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients.

Health Care · London$946K Grant
Arkivum
August 2021

Arkivum is a leading digital archiving and preservation SaaS provider.

Cloud Data Services · Reading$2.2M Private Equity
Lumenisity
July 2021

Lumenisity is developing advanced cable solutions to address the need for massive bandwidth increases in high capacity system.

Telecommunications · Romsey$6.9M Series C
MoA Technology
July 2026

MoA Technology is an agricultural biotech firm that develops safe and effective herbicides, ensuring sustainable weed control solutions.

Agriculture · Leeds$29.7M Series C
Sano Genetics
July 2024

Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.

Biopharma · CambridgeNon-equity Assistance
Mach42
July 2026

Mach42 is a University of Oxford spin-out commercializing new machine learning technology.

Artificial Intelligence (AI) · Oxford$9.4M Seed
Silicon MicroGravity
July 2026

Silicon MicroGravity is a company developing novel sensor technology.

Energy · Cambridge$8.1M Venture - Series Unknown
SERG Technologies
July 2022

SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before.

Health Diagnostics · London$1.9M Seed
Covatic
June 2026

Covatic is the use of mobile based algorithms to bring smart personalisation to apps.

Advertising · Birmingham$2.0M Series B
BibliU
June 2026

BibliU provides colleges and universities with digital content management, automation, and an analytics platform.

E-Learning · London$55.0M Private Equity
Gigaton
June 2026

Gigaton is a climate technology company developing artificial intelligence to decarbonize energy-intensive industries.

Artificial Intelligence (AI) · London$26.0M Series A
Oxa
March 2026

Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation.

Artificial Intelligence (AI) · Oxford$102.6M Series D
xWatts
February 2026

xWatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions.

Energy Management · London$2.2M Seed
Fresh Check
December 2025

Visible warning of bacterial infection in packaging.

Fitness · London$201K Series Unknown

Where Parkwalk Advisors invests

Software10
Biotechnology5
Health Care5
Artificial Intelligence (AI)5
Machine Learning4
Manufacturing3

About Parkwalk Advisors's portfolio

How many companies has Parkwalk Advisors invested in?

Parkwalk Advisors has invested in 173 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Parkwalk Advisors invest in?

Parkwalk Advisors's top investment sectors include Software, Biotechnology, Health Care, Artificial Intelligence (AI), Machine Learning. The firm invests across 51 different industry categories.

What is Parkwalk Advisors's largest investment?

Among tracked funding rounds, Oxa received $102.6M in a Series D round. Parkwalk Advisors's total known invested capital is $2.2B.

What is the average investment size for Parkwalk Advisors?

Parkwalk Advisors's average investment size is $14.2M across its portfolio of 173 companies.

What are Parkwalk Advisors's most recent investments?

Recent Parkwalk Advisors portfolio additions include Focal Point Positioning, PetMedix, Crypto Quantique, Opsydia, Trismik. These companies were founded in 2020 or later.

Reach the founders behind these 173 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →